Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

£0.5 million for UK cancer-depression correlation study:

This article was originally published in Clinica

Executive Summary

Cancer Research UK has provided £500,000 ($0.8m) to the University of Edinburgh to research the correlation between cancer and depression. A three-year study, led by Dr Michael Sharpe, in co-operation with the CRUK centre at Edinburgh's Western General Hospital, will seek to devise a care strategy that better accounts for the psychological problems that aggravate the effects of cancer and its treatment. Some 10% of the 5,000 patients who each year begin treatment at the hospital's oncology unit will suffer from depression.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT063442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel